Orbit system developer Gravitics (GVTX.US) has priced its IPO at $14-17 per share, aiming to raise $125 million.
Gravitics Holdings, focused on the research and development of large spatial structures and orbital systems, plans to issue 8.1 million shares of stock at a price of $14 to $17 per share, raising $125 million.
Gravitics Holdings, focused on the research and development of large space structures and orbital systems, announced its initial public offering (IPO) terms on Thursday. The company plans to issue 8.1 million shares at a price of $14 to $17 per share, aiming to raise $125 million. It intends to list on the NASDAQ under the ticker symbol GVTX.
As part of this NASDAQ IPO transaction, Gravitics will merge with the publicly traded shell company Non-Invasive Monitoring Systems (NIMU.US), which had previously been engaged in the development of a non-invasive whole-body periodic acceleration therapy platform. The latter ceased operations in 2019 and has since been seeking a reverse merger partner. Following the merger, the surviving entity will be renamed Gravitics Holdings.
Gravitics was founded in 2021 and is engaged in the design, development, and commercialization of large space structures, including orbital vehicles, cargo logistics spacecraft, space station modules, and related engineering and technical services. The company's primary client base includes government entities and the commercial space industry. Gravitics emphasizes its $125 million fixed-price contract with its affiliate Axiom Space for the development and delivery of cargo vehicles that will dock with Axioms commercial space station. Data indicates that the company achieved revenue of $400,000 in the 12 months ending March 31, 2026.
Related Articles

CF PHARMTECH (02652) has been awarded the 2026 Science and Technology Innovation Golden Bull Award, anchoring its global innovation strategy, and using inhalation formulation technology breakthroughs to redefine the future of respiratory therapy.

HK Stock Market Move | SYNAGISTICS (02562) once dropped 46% to hit a new low and was removed from the Hong Kong Stock Connect list, while the holdings of mainland investors still reached 40%.

Xiaomi Auto's cumulative delivery volume exceeds 800,000 units, and the Pengcheng series officially launches tonight.
CF PHARMTECH (02652) has been awarded the 2026 Science and Technology Innovation Golden Bull Award, anchoring its global innovation strategy, and using inhalation formulation technology breakthroughs to redefine the future of respiratory therapy.

HK Stock Market Move | SYNAGISTICS (02562) once dropped 46% to hit a new low and was removed from the Hong Kong Stock Connect list, while the holdings of mainland investors still reached 40%.

Xiaomi Auto's cumulative delivery volume exceeds 800,000 units, and the Pengcheng series officially launches tonight.

RECOMMEND





